COVID-19 Update: We are currently shipping orders daily. However, due to transit disruptions in some geographies, deliveries may be delayed. To provide all customers with timely access to content, we are offering 50% off Science and Technology Print & eBook bundle options. Terms & conditions.
Nanomedicines for Breast Cancer Theranostics - 1st Edition - ISBN: 9780128200162, 9780128200179

Nanomedicines for Breast Cancer Theranostics

1st Edition

Editors: Nanasaheb Thorat Joanna Bauer
Paperback ISBN: 9780128200162
eBook ISBN: 9780128200179
Imprint: Elsevier
Published Date: 8th March 2020
Page Count: 438
Sales tax will be calculated at check-out Price includes VAT/GST
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

1. Nanomedicine: next generation modality of breast cancer therapeutics
2. Physical and Chemical properties of nanostructures
3. Biological Perspectives of Hybrid nanostructures
4. Novel hybrid nanostructures in breast cancer nanomedicine
5. Synergy between nanoparticles and breast cancer theranostics
6. Remotely stimulated Nano medicine for breast cancer therapy
7. Functional Nanostructures for drug resistant breast cancer theranostics
8. Nanomedicine for early diagnosis of breast cancer
9. Nanomedicine strategies for chemoresistant breast cancer theranostics
10. Cellular Interaction and Toxicity of Nanostructures
11. Nano-pharmacokinetics, pharmacodynamics (PK/PD) and clinical relationship
12. A New Approach for Cancer Treatment: from Specific Induction of Breast Cancer to Innovative Gold-Nanoparticle Mediated Thermal Therapies
13. Development in efficacy assessment in relevant oncology models for breast cancer nanomedicine
14. Consensus protocols for animal experimentation and nanomedicine trials at clinical stage in breast cancer
15. Current development in toxicity, clinical trials guidelines for regulatory aspects of breast cancer nanomedicines
16. Breast cancer nanomedicine market update and other industrial perspectives of nanomedicine


Nanomedicines for Breast Cancer Theranostics addresses the translational aspects and clinical perspectives of breast cancer nanomedicine from a multidisciplinary perspective. The book summarizes research efforts at the preclinical and clinical stage of nanostructures and nanomedicine for dealing with the important challenge of nanomedicine translation in breast cancer theranostics. This book is an important resource for those working in both academia and industry, focusing on hot topics in biomaterials, biomedical engineering, drug delivery and oncology.

Key Features

  • Shows how the discovery of new nanomedicines is leading directly to an increase in the early-stage diagnosis of breast cancer
  • Includes coverage of breast cancer nanomedicine standardization and characterization, highlighting newly developed treatments, diagnostics and treatment monitoring tools
  • Explains why the design of nanobiomaterials make them effective drug carriers when treating breast cancer


Materials Scientists; Engineers; Oncologists; Pharmaceutical Scientists; Biomedical Researchers


No. of pages:
© Elsevier 2020
8th March 2020
Paperback ISBN:
eBook ISBN:

Ratings and Reviews

About the Editors

Nanasaheb Thorat

Dr. Nanasaheb Thorat is an outstanding Experienced Researcher currently working as a Marie Curie Fellow Research Scientist at the University of Oxford, Medical Science Division. Dr. Thorat is a two-time winner of the World's most prestigious fellowship, i.e. Marie Curie Fellowships and also working as an evaluation panel member of the Marie Curie Fellowships applications, for life and engineering sciences since the year 2019. Dr. Thorat has published 55 peer-reviewed journal research papers and articles, 1 international and European patent filled, 2 European innovations/inventions registered, 5 Books, 10 book chapters, presented 5 Keynote Speech, 20 invited lectures, and 5 oral presentations at prestigious scientific peer-conferences in Singapore, France, Germany, USA, Ireland, Poland, South Korea, and India, received international acclaims and awards for research contribution, generated research fund in excess of > €750,000, supervised students/junior researchers and actively participated in outreach and scientific dissemination for the service of the wider community. Dr. Thorat is the first Indian awardee of the European Commissions' Innovation Radar “Grand Prix of the Innovation Radar Prize 2020” and many other national and international acclaims on his name. Dr. Thorat is also the winner of other prestigious fellowships including, the Japanese Society for the Promotion of Science (JSPS) Fellowship in Japan (2017), PBC-Outstanding Fellowship, Israel (2016), and also worked as Senior Research Fellow at Samsung Biomedical Research Institute, South Korea (2014-2015). At the University of Oxford, He is working in the Medical Science Division jointly with the Engineering Science Division. His current research work involves designing new light-activated nanomedicine therapy and Raman imaging techniques for brain cancer of pediatric patients.

Affiliations and Expertise

Medical Science Division, Nuffield Department of Women's & Reproductive Health University of Oxford, Oxford, UK

Joanna Bauer

Joanna Bauer is Assistant Professor at the Department of Biomedical Engineering at the Wroclaw University of Science and Technology, Poland. Her research focuses on multidisciplinary biomedical engineering projects related to personalized and preventive medicine, nano-biomaterials synthesis, characterization and functionalization, biomedical optics using visible and infrared.imaging, as well as image analysis and pattern recognition.

Affiliations and Expertise

Assistant Professor, Department of Biomedical Engineering, Wroclaw University of Science and Technology, Poland